Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Wiping out mosquitoes on two Chinese islands, betting on biometrics to boost vaccination rates, and J&J to test HIV vaccine in US and Europe

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

David Jacobs
Research Roundup: Antibiotics, Zika vaccine R&D, and Ebola and malaria co-infection

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
GHTC
Farewell from the GHTC Director

Erin Will Morton offers farewell thoughts on her last day as GHTC's director.

GHTC
Read More
CDC/Sue Partridge, CDC- Ft. Collins
Twenty six current and past ASTMH presidents call for Congress to act on Zika funding

Twenty six current and past presidents of the American Society of Tropical Medicine and Hygiene sent a letter urging Congress to pass an emergency spending bill to combat the Zika virus as soon as possible.

Read More
PATH/Dan Chang
Research Roundup: Rapid test for bacterial infections, one drug to treat three neglected diseases, and innovations to combat Zika

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Courtney Carson/GHTC
From DC to Atlanta: Becoming Better Advocates for CDC Global Health Programs on Capitol Hill

Global health advocates traveled to the US Centers for Disease Control and Prevention last month. Here's what they learned about the agency's work.

Global Health Council
Read More
PATH/Evelyn Hockstein
Progress report on health R&D: A Q&A with USAID

USAID's Neal Brandes answers our questions about the agency's latest Health-Related Research and Development Progress Report and USAID's ongoing support for global health R&D.

Read More
Achim Hoerauf/Uniklinik Bonn
Research Roundup: Promising Zika drugs, micro-QR codes to fight counterfeit drugs, and a new antibiotic R&D accelerator

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Marissa Chmiola/GHTC
The potential, the pitch, and the prize: Innovators compete to save maternal and newborn lives

During the pitches at the Saving Lives at Birth DevelopmentXChange, the questions being asked were not how large the market, but how great the need, and not how much money can be made, but how many lives could be saved.

Read More
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Research Roundup: Placenta-on-a-chip, nasal bacteria against MRSA, and an experimental yellow fever vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
International Partnership for Microbicides
Research Roundup: The HIV/AIDS and STIs edition

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Update on Zika R&D

In this regular feature on Breakthroughs, we highlight the most promising Zika virus vaccine, drug, and diagnostic candidates as well as vector control approaches. 

GHTC
Read More
James Gathany
Research Roundup: Viral hepatitis, treatment for persistent Ebola, E. coli–based vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Sanofi Pasteur / Patrick Boulen
Yellow fever: Status of research, development, and access to countermeasures against an emerging epidemic

GHTC breaks down the status of R&D for vaccines, drugs, and diagnostics against yellow fever.

GHTC
Read More
PATH, as secretariat of GHTC
Eight keys to success in building an effective coalition

We share our lessons learned in building a diverse, effective advocacy coalition for global health R&D.

Read More
National Institute of Allergy and Infectious Diseases (NIAID)
Research Roundup: TB drug development, mosquitoes’ secret weapon, and a new platform for antibiotic R&D

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Celebrating over a decade of global health R&D advocacy

From humble origins to the premier advocacy organization focused on global health R&D. We tell the story of the birth of GHTC.

Read More
Architect of the Capitol
Research Roundup: Priority Review Voucher legislation, Toxic Shock Syndrome vaccine, and repurposing existing drugs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Schistosomiasis drug resistance, a nanotechnology vaccine platform, and adjusting doses to bolster the yellow fever vaccine supply

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Gabe Bienczycki
Research Roundup: Diagnostics for malaria, premature birth, and women’s health

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
US Navy
Senate votes to protect medical research at DoD

Today the US Senate voted to protect critical medical research programs at the Department of Defense (DoD).

GHTC
Read More